Document is current

Article History

Received: 24 July 2025

Accepted: 8 December 2025

First Online: 10 January 2026

Declarations

:

: Regina Gironés Sarrió, Victoria García Samblás, Mónica Guillot Morales, Patricia Palacios Ozores and Javier Torres-Jiménez declare that they have no conflicts of interest. Javier David Benítez Fuentes declares receipt of speaking and lecture fees and travel reimbursements from MSD and BMS. Ana Ruiz-Casado has received honoraria for speaker or advisor roles from Amgen, Servier, MSD, Takeda and Medtronic. María Vieito Villar has received honoraria for speaker or advisor roles from Laminar Pharmaceuticals, Novocure and Servier and as a steering committee member from BMS. She has also been a principal investigator on projects related to BMS, Debiopharm, Enterome, Hutchinson Pharma, Novartis, Roche and Tahio and has had a leadership role in the Grupo Español de Investigación en Neurología.

: This study involved an anonymous, voluntary, non-interventional online survey of healthcare professionals and collected no patient data and no identifying/sensitive personal data. In accordance with applicable Spanish regulations and institutional policy for anonymous, low-risk questionnaire research, formal Research Ethics Committee/IRB approval was not required. The study was conducted in accordance with the Declaration of Helsinki.

: Informed consent was obtained from all participants; completion and submission of the questionnaire implied consent.